🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objectives: * To determine the maximum tolerated dose, and dose li...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2012-03
Trial ID
NCT01511536
Treatments Being Tested
This randomized phase II trial studies how well androgen receptor antagonis...
Status
Active Not Recruiting
Location
Yale Cancer Center
Start Date
2017-06-20
Trial ID
NCT02949284
This is an exploratory Phase 2 multicenter, randomized, open-label study wi...
Status
Completed
Location
Gemeinschaftspraxis für Onkologie
Start Date
2014-05
Trial ID
NCT02077634
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of abir...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01795703
Treatments Being Tested
To assess activity of abiraterone-re-challenge in patients with advanced pr...
Status
Terminated
Location
Cantonal Hospital Chur
Start Date
2016-01
Trial ID
NCT02656615
Treatments Being Tested
The role of this study is to focus on the potential role of abiraterone ace...
Status
Completed
Location
Cork University Hospital
Start Date
2015-07-09
Trial ID
NCT02160353
Treatments Being Tested
Hormone tablets, abiraterone (Zytiga®) and enzalutamide (Xtandi®) are appro...
Status
Recruiting
Location
Border Medical Oncology Research Unit / The Border Cancer Hospital
Start Date
2022-11-10
Trial ID
NCT05393791
Treatments Being Tested
This multicenter randomized phase II trial investigates the impact of inten...
Status
Completed
Location
University of California, San Diego Moores Cancer Center
Start Date
2016-10-19
Trial ID
NCT02903368
Treatments Being Tested
Carcinomas of the salivary glands (SGCs) are rare tumors. Some selected sal...
Status
Completed
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2015-03
Trial ID
NCT02867852
Treatments Being Tested
This study is an open label, single arm, multicenter clinical trial. The ai...
Status
Recruiting
Location
The First Affiliated Hospital of China Medical University
Start Date
2024-11-27
Trial ID
NCT06971211